Mints, M
To summarize several meta-analyses of CVOTs conducted with GLP-1RAs, it isconfirmed that based on 43 trials, GLP-1RAs are a class of efficacious agent for reducing MACE (MH-OR 0.87 [0.83, 0.92]), cardiovascular and all-cause mortality (MH-OR 0.89 [0.83, 0.96]) [48]
Their effectiveness has revolutionized diabetes care, and brands like Ozempic and Mounjaro have become household names
Participants in the 2.4 mg cohort achieved an average loss of 18 kg absolute weight, though results ranged from minimal loss to over 30 kg
These opportunities have prompted regulators to act
You can join the Weight Watchers GLP-1 Program if youre on a second-generation GLP-1 (Wegovy, Ozempic, Zepbound, or Mounjaro) or if you are interested in this